Tranexamic Acid

Tranexamic Acid

SCHEMBL349408

NC[C@H]1CC[C@@H](C(=O)O)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PLG

The experimentally established mechanism targets of Tranexamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG known ✓ P00747 1/20 1.00
PLAT P00750 1/20 1.00
LMNA P02545 1/20 1.00
ANPEP P15144 1/20 0.52
ENPEP Q07075 1/20 0.52
CYP2D6 P10635 1/20 0.44
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
TSHR P16473 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
GABRA4 P48169 1/20 0.42
GABRE P78334 1/20 0.42
PMP22 Q01453 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tranexamic Acid SCHEMBL16974 1.00 PLG (1.00) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL423790 1.00 PLG (1.00) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL186034 1.00 PLG (1.00) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL322487 1.00 PLG (1.00) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL19031783 0.98 PLG (0.95) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL3793503 0.98 PLG (0.95) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL11189660 0.98 PLG (0.95) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL10723480 0.98 PLG (0.95) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL7326280 0.98 PLG (0.95) PLGPLATLMNAANPEPENPEP
Tranexamic Acid SCHEMBL29236634 0.98 PLG (0.95) PLGPLATLMNAANPEPENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346589-A1 RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS UNIV ERASMUS MED CT ROTTERDAM (NL) 2025-11-13 US claimed
WO-2025095745-A1 VASCULARIZATION SYSTEM FOR TRANSPLANTATION OF ENDOCRINE ORGANOIDS 서울대학교산학협력단 2025-05-08 WO claimed
EP-4529474-A1 RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS Erasmus University Rotterdam Medical Center (NL) 2025-04-02 EP claimed
WO-2024063648-A1 Platform and scaffold for FAP targeting agents ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) 2024-03-28 WO claimed
EP-4342890-A1 PLATFORM AND SCAFFOLD FOR FAP TARGETING AGENTS Erasmus University Rotterdam Medical Center (NL) 2024-03-27 EP claimed
WO-2023229458-A1 RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) 2023-11-30 WO claimed
EP-4282439-A1 RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS Erasmus University Rotterdam Medical Center (NL) 2023-11-29 EP claimed
US-20180110658-A1 Thin Patch LIN HSUEH YA (TW) 2018-04-26 US claimed
EP-2986117-A1 BINARY INSECTICIDAL OR PESTICIDAL MIXTURE Bayer CropScience Aktiengesellschaft (DE) 2016-02-24 EP claimed
WO-2016001125-A1 ACTIVE COMPOUND COMBINATIONS AND METHODS TO PROTECT THE PROPAGATION MATERIAL OF PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-01-07 WO claimed
US-20060018933-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
US-20060018934-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
EP-1581269-A1 HAEMOSTATIC WOUND DRESSING Langer, Hans-Georg (DE) 2005-10-05 EP claimed
WO-2004054632-A1 HAEMOSTATIC WOUND DRESSING LANGER, HANS-GEORG (DE) 2004-07-01 WO claimed
EP-0728730-B1 Process for preparing monochloroacetic acid SALZGITTER ANLAGENBAU GMBH (DE) 2001-03-07 EP claimed
WO-1998000161-A1 FIBRIN-BASED SYSTEMS FOR THE CONTROLLED RELEASE OF MEDICINALS BUFORD BIOMEDICAL, INC. (US) 1998-01-08 WO claimed
EP-0329105-B1 MOLECULAR WEIGHT CONTROLLER FOR POLYMERIZATION OF LACTAMS TO POLYAMIDES BASF Corporation (US) 1993-07-07 EP claimed
US-5006635-A Monofunctional amine, monofunctional acid, salt of aminoacid, polyamides BASF CORPORATION (US) 1991-04-09 US claimed
EP-0329105-A2 Molecular weight controller for polymerization of lactams to polyamides BASF Corporation (US) 1989-08-23 EP claimed
US-4844834-A Molecular weight controller for polymerization of lactams to polyamides BASF CORPORATION (US) 1989-07-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346589-A1 RADIOISOTOPE LABELED SSTR2-AGONISTS WITH LINKERS SSTR2, SSTR5, SSTR1 PLG 2667/4885PLAT 3407/4885LMNA 1849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.